secwatch.observer — SEC 8-K summary
======================================

Issuer:     Werewolf Therapeutics, Inc. (HOWL)
CIK:        0001785530
Form:       8-K
Filed at:   2024-05-28T23:59:59+00:00
Accession:  0001193125-24-148114
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Werewolf Therapeutics shareholders elect three Class III directors, ratify EY auditor
--------------------------------------------------------------------------------

- Elected Michael Atkins, Luke Evnin, and Alon Lazarus as Class III directors; Atkins 31.6M votes for, Evnin 20.7M, Lazarus 31.5M.
- Broker non-votes of 5.1M shares on each director election.
- Ratified Ernst & Young as independent auditor for FY2024: 36.7M for, 41.9K against, 2.9K abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1785530/000119312524148114/0001193125-24-148114-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1785530/000119312524148114/d794252d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-148114

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer